Skip to main content
. 2015 Aug 26;75(16):1857–1867. doi: 10.1002/pros.23059

Figure 3.

Figure 3

Cumulative favourable effect by mRNA gene at the end of treatment (D90). For each mRNA gene, the global favourable effect corresponding to the sum of the delta of patients between treatment groups for downregulation and delta of patients for less upregulation was calculated. This was followed by a classification by group. Asterix * denoted nominally significant at P < 0.05.